Search by Drug Name or NDC
NDC 50090-2200-01 Sulfamethoxazole and Trimethoprim 800; 160 mg/1; mg/1 Details
Sulfamethoxazole and Trimethoprim 800; 160 mg/1; mg/1
Sulfamethoxazole and Trimethoprim is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is SULFAMETHOXAZOLE; TRIMETHOPRIM.
MedlinePlus Drug Summary
Co-trimoxazole is used to treat certain bacterial infections, such as pneumonia (a lung infection), bronchitis (infection of the tubes leading to the lungs), and infections of the urinary tract, ears, and intestines. It also is used to treat 'travelers' diarrhea. Co-trimoxazole is a combination of trimethoprim and sulfamethoxazole and is in a class of medications called sulfonamides. It works by stopping the growth of bacteria. Antibiotics will not kill viruses that can cause colds, flu, or other viral infections.
Related Packages: 50090-2200-01Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Co-trimoxazole
Product Information
| NDC | 50090-2200 |
|---|---|
| Product ID | 50090-2200_7bd2f878-cad0-454c-9d81-6536a44adcc2 |
| Associated GPIs | 16990002300320 |
| GCN Sequence Number | 009396 |
| GCN Sequence Number Description | sulfamethoxazole/trimethoprim TABLET 800-160 MG ORAL |
| HIC3 | W2A |
| HIC3 Description | ABSORBABLE SULFONAMIDE ANTIBACTERIAL AGENTS |
| GCN | 90163 |
| HICL Sequence Number | 004071 |
| HICL Sequence Number Description | SULFAMETHOXAZOLE/TRIMETHOPRIM |
| Brand/Generic | Generic |
| Proprietary Name | Sulfamethoxazole and Trimethoprim |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sulfamethoxazole and Trimethoprim |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 800; 160 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | SULFAMETHOXAZOLE; TRIMETHOPRIM |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Su |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090624 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-2200-01 (50090220001)
| NDC Package Code | 50090-2200-1 |
|---|---|
| Billing NDC | 50090220001 |
| Package | 14 TABLET in 1 BOTTLE (50090-2200-1) |
| Marketing Start Date | 2023-12-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |